Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    23228172 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed OGX-427 in Castration Resistant Prostate Cancer Patients
Condition: Castration Resistant Prostate Cancer
Interventions: Drug: OGX-427;   Drug: Prednisone
2 Recruiting A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.
Condition: Carcinoma Prostate
Intervention: Drug: Xtandi
3 Not yet recruiting Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Condition: Prostate Cancer
Interventions: Drug: Apalutamide;   Drug: Abiraterone;   Drug: ADT;   Drug: Prednisone
4 Active, not recruiting
Has Results
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Placebo;   Drug: Prednisone

Study has passed its completion date and status has not been verified in more than two years.